Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07087093Recruiting
Ketone drink effects on aging immune cells in healthy older adults
This study tests whether a special drink called a ketone ester can reduce inflammation and improve immune cell health in healthy older adults. It aims to see if this drink helps aging immune cells (T cells) work better.
Harbin, HeilongjiangAges 65–80 - NCT07087106RecruitingPhase 4
Glucose use in the brain of people with MS
This study uses a special PET scan to see how the brain uses sugar (glucose) in people with multiple sclerosis (MS) compared to healthy volunteers. It may help researchers understand energy changes in the brain related to MS.
Boston, MassachusettsAges 18–70 - NCT07087366Recruiting
Enhanced recovery after gynecologic cancer surgery
This trial tests a program to help women recover faster after surgery for cervical, uterine, or ovarian cancer. It focuses on improving recovery steps to reduce hospital stay and make the process smoother.
DhakaAges 18–70 - NCT07087431Recruiting
Genetic risk score for heart disease and health habits
This study looks at whether sharing a genetic risk score for heart disease can help people make heart-healthy changes. If you're not on cholesterol medication, you may be able to join.
Boston, MassachusettsAges 30–75 - NCT07087418Recruiting
AI imaging study for digestive diseases (IBD, TB, Behçet's)
This trial uses artificial intelligence to combine CT/MR scans and colonoscopy images to better diagnose and predict outcomes for people with inflammatory bowel disease, intestinal tuberculosis, or Behçet's disease. It aims to see if AI can help doctors make more accurate decisions.
ShanghaiAges Any age - NCT07087626Recruiting
COPD test scores and surgery risks
This study looks at whether a simple COPD assessment test score can predict how well patients with stable COPD do after planned surgery. It may help doctors better understand and manage risks for people like you.
Erzurum, YakutiyeAges 40–70 - NCT07087782Recruiting
Early high-calorie formula for infants with single ventricle heart condition
This trial tests whether starting a special high-calorie formula (Fortini) early helps infants with a single ventricle heart condition grow better and have fewer health problems between surgeries. It might improve outcomes before their next surgery.
Corpus Christi, TexasAges birth–6 months - NCT07087912RecruitingPhase 4
Dengue vaccine safety in people with autoimmune rheumatic diseases
This study tests the safety and immune response of a dengue vaccine in people aged 12–59 with stable autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are on low-dose or no immune-suppressing medications. It also includes healthy volunteers for comparison.
São Paulo, São PauloAges 12–59 - NCT07087873Recruiting
Testing brain stimulation for memory problems in inflammatory diseases
This trial tests if a gentle electrical current applied to the scalp can improve memory and thinking in people with certain inflammatory conditions that affect the brain and spinal cord.
Beijing, Beijing MunicipalityAges 18–60 - NCT07088211RecruitingPhase 2
New drug combo for first-line head and neck cancer
This trial tests a new drug combination (sacituzumab tirumotecan and toripalimab) as a first treatment for people with advanced head and neck squamous cell carcinoma that cannot be removed with surgery. The goal is to see if this treatment shrinks tumors and improves outcomes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07088250Recruiting
Statins for Treating Brain Bleeding
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
Anqing, AnhuiAges 18–80 - NCT07088354Recruiting
AI model predicts treatment response in esophageal cancer
This trial tests whether an artificial intelligence (AI) model can accurately predict if esophageal cancer will completely disappear after chemotherapy combined with immunotherapy before surgery. If successful, it could help doctors decide the best treatment plan for patients.
Wuhan, HubeiAges 18 years+ - NCT07088640Recruiting
Comparing two ways to warm frozen embryos for transfer
This trial compares two methods of warming frozen embryos before transfer—one with a single step and one with multiple steps. It aims to see which approach leads to better pregnancy outcomes for women using their own frozen embryos.
Ho Chi Minh City, CityAges 18 years+ - NCT07088874Recruiting
New markers for kidney injury after nephrectomy
This study looks at new markers in blood or urine to help predict kidney injury after surgery to remove a kidney. It may help doctors better understand how to protect your remaining kidney after surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07089095Recruiting
Choosing rehab after a stroke: your preferences matter
This study looks at what matters to you when choosing rehabilitation care after a recent stroke. By joining, you can help doctors understand how to better support people like you in recovery.
TaipeiAges 18 years+ - NCT07089173Recruiting
Testing lidocaine or sufentanil to ease breathing tube placement
This trial tests whether adding lidocaine or sufentanil to a standard anesthetic drug (etomidate) helps reduce the dose of remifentanil needed to place a breathing tube comfortably. It may help patients undergoing planned surgery with general anesthesia.
Shenzhen, GuangdongAges 18–65 - NCT07089186RecruitingPhase 3
Study of meropenem and pralurbactam for certain antibiotic-resistant infections
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
ShanghaiAges 18–80 - NCT07089303Recruiting
Alzheimer's brain imaging study (AD-MINER)
This study uses advanced brain imaging to learn more about Alzheimer's disease. It looks at people with normal memory, mild memory problems, or Alzheimer's dementia to find better ways to diagnose and track the disease.
Beijing, Beijing MunicipalityAges 55–90 - NCT07090200Recruiting
Rehabilitation program for COPD with heart or blood vessel disease
This study tests a rehabilitation program for people with COPD who also have heart or blood vessel problems. It aims to help you breathe better and improve your overall health.
Wuhan, HubeiAges 18 years+ - NCT07090317RecruitingPhase 2
Testing Two Immunotherapy Drugs for Advanced Head and Neck Cancer
This trial tests two new immunotherapy drugs, iparomlimab and tuvonralimab, for people with head and neck squamous cell cancer that has spread or come back after at least 2 prior treatments. The goal is to see if this combination can shrink or slow the cancer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07090837Recruiting
Support study for caregivers of older adults
This study tests whether using a mobile app can help support caregivers of older adults receiving home-based care. It aims to see if this improves caregiver well-being.
SingaporeAges Any age - NCT07090928RecruitingPhase 4
Numbing medicine for less pain after knee scope surgery
This study tests whether giving bupivacaine (a numbing medicine) around the time of knee arthroscopy can reduce pain at the surgery sites and help you move your knee better after the operation.
Peshawar, KPKAges 18–70 - NCT07091032Recruiting
Building connections for better health
This study tests if helping people address obesity, cancer screenings, or mental health struggles can improve their overall health. You may qualify if you have obesity, are behind on colon or cervical cancer screening, or have depression or anxiety.
Boston, MassachusettsAges 18–75 - NCT07091175RecruitingPhase 2
Dupilumab for nephrotic syndrome in children
This trial tests if dupilumab can help children with nephrotic syndrome who still have relapses despite standard treatments. It aims to find a better way to control the disease and reduce steroid side effects.
Singapore, SingaporeAges 6–18
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.